Application
Mouse Hras1 Antibody (C-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the Mouse Hras1 antibody detected the Mouse Hras1 protein (arrow).| Product Name | Hras1 (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | Hras1; Hras; GTPase HRas; H-Ras-1; Transforming protein p21; c-H-ras; p21ras; GTPase HRas, N-terminally processed |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | Hras |
|---|---|
| Alternative Names | Hras1 Hras GTPase HRas H-Ras-1 Transforming protein p21 c-H-ras p21ras GTPase HRas N-terminally processed |
| Molecular Weight(MW) | 21298 Da |
| Function | Ras proteins bind GDP/GTP and possess intrinsic GTPase activity |
| Tissue Specificity | This Mouse Hras1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 151-179 amino acids from the C-terminal region of human Mouse Hras1. |
| Cellular Localization | Cell membrane (By similarity). Cell membrane; Lipid-anchor; Cytoplasmic side (By similarity). Golgi apparatus (By similarity). Golgi apparatus membrane; Lipid-anchor (By similarity). Note=Shuttles between the plasma membrane and the Golgi apparatus. The active GTP-bound form is localized most strongly to membranes than the inactive GDP-bound form (By similarity) |
| Entrez Gene | 15461 |
|---|
Application
Mouse Hras1 Antibody (C-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the Mouse Hras1 antibody detected the Mouse Hras1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
